A novel approach to the determination and characterization of HIV dementia

Canadian Journal of Neurological Sciences

Volumn 23, Issue 2, 1996, Pages 104-109

  Brouwers, P ^a   Mohr, E ^c   Hildebrand, K ^c   Hendricks, M ^a   Claus, J J ^b   Baron, I S ^d   Young, M ^d   Pierce, P ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF OTTAWA   (Canada)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DEMENTIA; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NERVE DEGENERATION; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0029973428     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100038804     Document Type: Article

References (60)

1. Brouwers P, Mohr E, Hendricks M, Baron I. The use of discriminant analysis to differentiate the neuropsychological profile of HIV patients. J Clin Exp Neuropsychol 1989; 11: 35.
2. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986; 19: 517-524.
3. Price RW, Brew B, Sidtis J, et al. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988; 239: 586-592.
4. Shaw GM, Harper ME, Hahn BH, et al. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 1985; 227: 177-182.
5. Koenig S, Gendelman HE, Orenstein JM, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patient with encephalopathy. Science 1986; 233: 1089-1093.
6. Resnick L, DiMarzo-Veronese F, Schupbach J, et al. Intra-blood-brain barrier synthesis of HTLV-III specific IgG in patients with neurological symptoms associated with AIDS or AIDS-related complex. N Engl J Med 1985; 313: 1498-1504.
7. Hollander H. Cerebrospinal fluid normalities and abnormalities in individuals infected with human immunodeficiency virus. J Infect Dis 1988; 158: 855-858.
8. McArthur JC, Cohen BA, Farzedegan H, et al. Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings. Ann Neurol 1988; 23 (Suppl.): S34-S37.
9. American Academy of Neurology (AAN) AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 infection. Neurology 1991; 41: 778-785.
10. Price RW, Brew BJ, Rosenblum M. The AIDS dementia complex and HIV-1 brain infection: a pathogenetic model of virus-immune interaction. Res Publ Assoc Res Nerv Ment Dis 1990; 68: 269-290.
11. Brew BJ, Currie JN. HIV-related neurological disease. Med J Aust 1993; 158: 104-108.
12. Janssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 1992; 42: 1472-1476.
13. Grant I, Atkinson JH, Hesselink JR, et al. Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med 1987; 107: 828-836.
14. McArthur JC, Cohen BA, Selnes OA, et al. Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1-infected individuals: results from the Multicenter AIDS Cohort Study. Ann Neurol 1989; 26: 601-611.
15. Selnes OA, Miller E, McArthur J, et al. HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. Neurology 1990; 40: 204-208.
16. Bornstein RA, Pace P, Rosenberger P, et al. Depression and neuropsychological performance in asymptomatic HIV infection. Am J Psychiatry 1993; 150: 922-927.
17. Wilkie FL, Eisdorfer C, Morgan R, Loewenstein DA, Szapocznik J. Cognition in early human immunodeficiency virus infection. Arch Neurol 1990; 47: 433-440.
18. Lunn S, Skydsbjerg M, Schulsinger H, et al. A preliminary report on the neuropsychologic sequelae of Human Immunodeficiency Virus. Arch Gen Psychiatry 1991; 48: 139-142.
19. Adams KM, Heaton RK. Statement concerning the NIMH neuropsychological battery. J Clin Exp Neuropsychol 1990; 12: 960-962.
20. Mohr E, Brouwers P, Claus JJ, et al. Differential classification of dementia. Behavioural Neurology 1995; 8: 23-30.
21. Cummings JL. Subcortical Dementia, New York: Oxford University Press, 1990:
22. Tolosa ES, Alvarez R. Differential diagnosis of cortical vs. subcortical dementing disorders. Acta Neurol Scand 1992; 139: 47-53.
23. Mayeux R, Denaro J, Hemenegildo N, et al. A population-based investigation of Parkinson's disease with and without dementia: relationship to age and gender. Arch Neurol 1992; 49: 492-497.
24. Yarchoan R, Berg G, Brouwers P, et al. Response of Human-Immuodeficiency-Virus-associated neurological disease to 3′-Azido-3′-Deoxythymidine. Lancet 1987; 1: 132-135.
25. Schmitt F, Bigley J, McKinnis R, et al. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med 1988; 319: 1573-1578.
26. Sidtis JJ, Gatsonis C, Price RW, et al. Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. Ann Neurol 1993; 33: 343-349.
27. Wechsler D. Wechsler Adult Intelligence Scale-Revised, New York: The Psychological Corporation, 1981.
28. Wechsler D, Stone CP. Wechsler Memory Scale, New York: The Psychological Corporation, 1945.
29. Osborne D, Davis LJ. Standard Scores for Wechsler Memory Scale Subtests. J Clin Psychol 1978; 34: 115-116.
30. Kirk RE. Experimental design: procedures of the behavioral sciences, Belmont, CA: Brooks/Cole Publishing Co., 1968.
31. Raven JC. Guide to Using the Coloured Progressive Matrices. London: H.K. Lewis, 1965.
32. Dunn LM. Peabody Picture Vocabulary Test - Revised Manual, Circle Pines, MN: American Guidance Service, 1981.
33. Jastak S, Wilkinson G. The Wide Range Achievement Test-Revised: Administration Manual, Wilmington, DE: Jastak Associates, 1984.
34. Spreen O, Benton AL. Neurosensory Center Comprehensive Examination for Aphasia (NCCEA), Victoria: University of Victoria, Neuropsychology Laboratory, 1977.
35. Money JA. Standardized Road Map of Direction Sense, San Rafael, CA. Academic Therapy Publications, 1976.
36. Lezak MD. Neuropsychological Assessment, 2nd edition. New York: Oxford University Press, 1983.
37. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
38. Navia BA. The AIDS dementia complex. In: Cummings JL, ed. Subcortical Dementia, New York: Oxford University Press, 1990: 181-198.
39. Chui HC. Dementia: a review emphasizing clinicopathologic correlation and brain - behavior relationships. Arch Neurol 1989; 46: 806-814.
40. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986; 19: 525-535.
41. Budka H, Costanzi G, Cristina S, et al. Brain pathology induced by infection with the human immunodeficiency virus (HIV): a histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol 1987; 75: 185-198.
42. Aylward EH, Henderer JD, McArthur JC, et al. Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 1993; 43: 2099-2104.
43. Rottenberg DA, Moeller JR, Strother SC, et al. The metabolic pathology of the AIDS dementia complex. Ann Neurol 1987; 22: 700-706.
44. Brunetti A, Berg G, Di Chiro G, et al. Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3′-azido-2′,3′-dideoxythymidine (AZT, zidovudine): a PET-FDG study. J Nucl Med 1989; 30: 581-590.
45. Brouwers P, Cox CS, Martin A, Chase TN, Fedio P. Differential perceptual-spatial impairment in Huntington's and Alzheimer's dementias. Arch Neurol 1984; 41: 1073-1076.
46. Mohr E, Brouwers P, Claus JJ, et al. Visuospatial cognition in Huntington's disease. Mov Disord 1991; 6: 127-132.
47. Perdices M, Cooper DA. Simple and choice reaction time in patients with human immunodeficiency virus infection. Ann Neurol 1989; 25: 460-467.
48. Miller EN, Satz P, Visscher B. Computerized and conventional neuropsychological assessment of HIV-1 infected homosexual men. Neurology 1991; 41: 1608-1616.
49. Wilkie FL, Morgan R, Fletcher MA, et al. Cognitive and immune function in HIV-1 infection. AIDS 1992; 6: 977-981.
50. Martin A, Heyes MP, Salazar AM, et al. Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals. Neuropsychiatr Clin Neurosci 1992; 4: 270-279.
51. Podraza AM, Bornstein RA, Whitacre CC, et al. Neuro-psychological performance and CD4 levels in HIV-1 asymptomatic infection. J Clin Exp Neuropsychol 1994; 16: 777-783.
52. Grant I, Atkinson JH. Neurogenic and psychogenic behavioral correlates of HIV infection. Res Publ Assoc Res Nerv Ment Dis 1990; 68: 291-304.
53. Hollander H. Neurologic and psychiatric manifestations of HIV disease. J Gen Int Med 1991; 6 (Jan/Feb Suppl.): S24-S31.
54. Rubinow DR, Berrettini CH, Brouwers P, Lane HC. Neuropsychiatric consequences of AIDS. Ann Neurol 1988; 23 (Suppl.): S24-S26.
55. Schmitt FA, Dickson LR, Brouwers P. Neuropsychological response to anti-retroviral therapy in HIV infection. In: Grant I, Martin A, eds. Neuropsychology of HIV infection: current research and new directions, Oxford: Oxford University Press, 1994: 276-294.
56. Pizzo PA, Eddy J, Falloon J, et al. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med 1988; 319: 889-896.
57. Yarchoan R, Pluda JM, Thomas RV, et al. Long-term toxicity/activity profile of 2′,3′-dideoxyinosine in AIDS or AIDS-related complex. Lancet 1990; 336: 526-529.
58. Brouwers P, Moss H, Wolters P, et al. Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immuno-deficiency virus infection. J Pediatr 1990; 117: 980-985.
59. Balis FM, Pizzo PA, Butler KM, et al. Clinical pharmacology of 2′,3′-dideoxyinosine in human immunodeficiency virus-infected children. J Infect Dis 1992; 165: 99-104.
60. Brouwers P, DeCarli C, Tudor-Williams G, et al. Interrelations among patterns of change in neurocognitive, CT brain imaging, and CD4 measures associated with anti-retroviral therapy in children with symptomatic HIV infection. Adv Neuroimmunol 1994; 4: 223-231.